CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 77 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $35,055 | -33.9% | 80,792 | 0.0% | 0.00% | – |
Q4 2022 | $53,016 | -23.2% | 80,792 | 0.0% | 0.00% | – |
Q3 2022 | $69,000 | +56.8% | 80,792 | 0.0% | 0.00% | – |
Q2 2022 | $44,000 | -51.1% | 80,792 | 0.0% | 0.00% | – |
Q1 2022 | $90,000 | -35.3% | 80,792 | 0.0% | 0.00% | – |
Q4 2021 | $139,000 | -36.8% | 80,792 | +12.4% | 0.00% | – |
Q3 2021 | $220,000 | -12.7% | 71,880 | +11.2% | 0.00% | – |
Q2 2021 | $252,000 | -62.2% | 64,616 | -73.0% | 0.00% | – |
Q1 2021 | $667,000 | -15.2% | 239,015 | -7.0% | 0.00% | – |
Q4 2020 | $787,000 | -51.4% | 257,044 | -3.4% | 0.00% | – |
Q3 2020 | $1,618,000 | +11.1% | 266,093 | +8.0% | 0.00% | – |
Q2 2020 | $1,456,000 | +100.8% | 246,442 | -10.0% | 0.00% | – |
Q1 2020 | $725,000 | -7.1% | 273,741 | -4.6% | 0.00% | – |
Q4 2019 | $780,000 | -77.3% | 286,960 | +1.3% | 0.00% | -100.0% |
Q3 2019 | $3,433,000 | +57.8% | 283,294 | +49.0% | 0.00% | 0.0% |
Q2 2019 | $2,176,000 | +1218.8% | 190,151 | +1681.4% | 0.00% | – |
Q1 2019 | $165,000 | – | 10,674 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 325,000 | $861,000 | 4.66% |
MFN Partners Management, LP | 2,427,677 | $6,433,000 | 0.85% |
EcoR1 Capital, LLC | 2,742,276 | $7,267,000 | 0.76% |
Slate Path Capital LP | 1,196,063 | $3,170,000 | 0.24% |
Eversept Partners, LP | 337,145 | $893,434 | 0.22% |
Artal Group S.A. | 1,861,584 | $4,933,000 | 0.21% |
Alambic Investment Management, L.P. | 21,265 | $56,000 | 0.14% |
TRUSTCORE FINANCIAL SERVICES, LLC | 198,106 | $525,000 | 0.12% |
SPHERA FUNDS MANAGEMENT LTD. | 124,976 | $331,000 | 0.04% |
Broderick Brian C | 32,175 | $86,000 | 0.03% |